// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "HTML INITIATIVE HCD URI MIAME EBI NCE PSI JA PRIDE PRIDE:0000832 HF REQUIRES THE SILAC cleavage agent details FOR ZFA MS:1001251 CL TO proteomics data acquisition method PP PRM OF fractionation method MT ancestry category XML CELL developmental stage source name CT CS PRIDE:0000659 PO PRIDE:0000590 NOTE PMCID WILL spiked compound age cell type SHOULD HEREIN collision energy THAT PRIDE:0000831 TMT instrument CV TA HANCESTRO BUT NCIT:C25714 SDRF SN QY MIAPE VCF RAW SAMEA file your II alkylation reagent SAMN technical replicate MC PURPOSE ANY MOD LIMITED BE LI MAGE PATCH PRIDE:0000834 DIA fraction identifier SWATH PARTICULAR ID README CID FITNESS MERCHANTABILITY MHC YAML biosample accession number SH XL INFRINGE depletion RECOMMENDED MS CF III NT PMID ISA IS URL HLA BMC AND MAJOR ROW PEPTIDESEQ EW DTT MS:1000484 LC COULD RFC BRENDA biological replicate OR COLUMN EFO not REQUIRED characteristics EM NCIT:C25683 INCLUDING disease HUPO STANDARDS NCI NCIT NOT WARRANTIES FAIR dissociation method ... UBERON reduction reagent ALL exclamation RIGHTS SHALL IMPLIED organism EXPRESS SP OPTIONAL USE pooled sample PS PROTEOMICS PRIDE:0000833 CN TAB SRM WARRANTY AC CLO mass IDF TIP data file CPTAC IAA IMPORTANT BTO DJ VK FDR individual DDA AS MAY MINOR MONDO PTM MUST organism part label ENVO PATO sample RECOMMEND NCBI PATO:0000461 DISCLAIMS sex INFORMATION"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "HTML INITIATIVE HCD URI MIAME EBI NCE PSI JA PRIDE PRIDE:0000832 HF REQUIRES THE SILAC cleavage agent details FOR ZFA MS:1001251 CL TO proteomics data acquisition method PP PRM OF fractionation method MT CELL CT CS PRIDE:0000659 PO PRIDE:0000590 PMCID WILL spiked compound age cell type SHOULD HEREIN collision energy THAT PRIDE:0000831 TMT instrument CV TA HANCESTRO BUT NCIT:C25714 SDRF SN QY MIAPE VCF RAW SAMEA II alkylation reagent SAMN technical replicate MC PURPOSE ANY MOD LIMITED BE LI MAGE PATCH PRIDE:0000834 DIA fraction identifier SWATH PARTICULAR README CID FITNESS MERCHANTABILITY MHC YAML biosample accession number SH XL INFRINGE depletion RECOMMENDED MS CF III NT PMID ISA IS URL HLA BMC AND MAJOR ROW PEPTIDESEQ EW DTT MS:1000484 LC COULD RFC BRENDA biological replicate OR COLUMN EFO REQUIRED EM NCIT:C25683 INCLUDING disease HUPO STANDARDS NCI NCIT NOT WARRANTIES FAIR dissociation method ... UBERON reduction reagent ALL RIGHTS SHALL IMPLIED organism EXPRESS SP OPTIONAL USE pooled sample PS PROTEOMICS PRIDE:0000833 CN TAB SRM WARRANTY AC CLO mass IDF data file CPTAC IAA BTO DJ VK FDR individual DDA AS MAY MINOR MONDO PTM MUST organism part label ENVO PATO RECOMMEND NCBI PATO:0000461 DISCLAIMS INFORMATION"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON PATO:0001421 xenograft CL:0000624 exclamation organism APP CL:0000815 SDRF MONDO:0004989 MONDO:0004975 CL:0000066 CL PDX EFO developmental stage UBERON:0000178 DOID disease enrichment process ID PO MONDO:0005148 MONDO MAY PTM UBERON:0002107 MUST organism part NOTE PATO NCBI PATO:0000461 depletion age synthetic peptide CL:0000084 cell type"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON PATO:0001421 xenograft CL:0000624 organism APP CL:0000815 SDRF MONDO:0004989 MONDO:0004975 CL:0000066 CL PDX EFO developmental stage UBERON:0000178 DOID disease enrichment process ID PO MONDO:0005148 MONDO MAY PTM UBERON:0002107 MUST organism part PATO NCBI PATO:0000461 depletion age synthetic peptide CL:0000084 cell type"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "treatment response HANCESTRO:0009 breast cancer subtype exclamation Ann Arbor stage weight HANCESTRO SDRF menopausal status TNM NCIT:C28078 tumor grade NCIT:C65106 IV treatment TNM staging pre-existing condition treatment status ancestry category HANCESTRO:0005 NCIT:C71732 IMPORTANT CHEBI:28748 smoking status Dukes stage NCIT:C15262 GDPR CHEBI:27899 disease stage ID AJCC individual PR sampling time point MONDO:0005148 NCIT:C27966 MONDO compound NCIT:C65107 organism part NCI body mass index NCIT HIPAA NCIT:C4870 NCIT:C28076 NCIT:C18206 NCIT:C27971 dose ER NCIT:C65108 NCIT:C15632 NCIT:C53554 MONDO:0005044"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "treatment response HANCESTRO:0009 breast cancer subtype Ann Arbor stage weight HANCESTRO SDRF menopausal status TNM NCIT:C28078 tumor grade NCIT:C65106 IV treatment TNM staging pre-existing condition treatment status ancestry category HANCESTRO:0005 NCIT:C71732 CHEBI:28748 smoking status Dukes stage NCIT:C15262 GDPR CHEBI:27899 disease stage ID AJCC individual PR sampling time point MONDO:0005148 NCIT:C27966 MONDO compound NCIT:C65107 organism part NCI body mass index NCIT HIPAA NCIT:C4870 NCIT:C28076 NCIT:C18206 NCIT:C27971 dose ER NCIT:C65108 NCIT:C15632 NCIT:C53554 MONDO:0005044"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole, TOF.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 NT HCD PRIDE:0000285 UNIMOD exclamation scan window lower limit PSI TMT PRIDE CV TA modification parameters HF SILAC SDRF cleavage agent details AC PRIDE:0000564 MS:1001251 fragment mass tolerance PP TOF precursor mass tolerance MT MOD REQUIRED MS:1002523 DIA MS2 mass analyzer UNIMOD:35 MS1 scan range README PRIDE:0000590 label NOTE scan window upper limit MS UNIMOD:4"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole, TOF.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 NT HCD PRIDE:0000285 UNIMOD scan window lower limit PSI TMT PRIDE CV TA modification parameters HF SILAC SDRF cleavage agent details AC PRIDE:0000564 MS:1001251 fragment mass tolerance PP TOF precursor mass tolerance MT MOD REQUIRED MS:1002523 DIA MS2 mass analyzer UNIMOD:35 MS1 scan range PRIDE:0000590 label scan window upper limit MS UNIMOD:4"
  }
];
